Institute of Inflammation and Ageing From basic science to clinical trials, we cover every aspect of research into inflammation, the role it plays in ageing and the response to trauma.
25/10/2019 Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation
16/10/2019 Global trial is first clear evidence that a widely available drug reduces head injury deaths
Posted 07 November 2019 Researchers find potential new target for treatment of inflammatory disease Researchers led by the University of Birmingham have found a potential new target to treat inflammatory disease. The research has been published in Cell Metabolism.
Posted 25 October 2019 Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation Researchers at the University of Birmingham awarded £1.15 million for latest equipment for immune regulation.
Posted 25 October 2019 University of Birmingham expert plays key role in new report on healthy ageing A University of Birmingham expert has played a pivotal part in the production of a new report aimed at highlighting physiology's role in meeting the UK Government's healthy ageing mission.
Posted 16 October 2019 Global trial is first clear evidence that a widely available drug reduces head injury deaths A low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20% depending on the severity of injury, according to a study carried out with the University of Birmingham.
Posted 25 September 2019 Award winning researcher joins as Hale-Rudd Lecturer in Experimental Ophthalmology Dr Jose M Romero Hombrebueno has moved from Belfast to Birmingham to join the Institute of Inflammation and Ageing as a Hale-Rudd Lecturer in Experimental Ophthalmology.
Posted 14 September 2019 Pioneering data research centres to enable cutting-edge research and innovation to benefit UK patients The University of Birmingham will play a key role in new data hubs that will enable cutting-edge research for health discoveries and aim to give patients across the UK faster access to pioneering new treatments.